O'Callaghan Brian
SEC-identified person · CIK 1415015 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Bolt Biotherapeutics, Inc. BOLT | Director | filed 2021–2026 |
| Obseva SA OBSV | Director · Chief Executive Officer | filed 2023–2023 |
| Intec Parent Inc. NTEC | Director | filed 2021–2022 |
| Kubota Pharmaceutical Holdings CO LTD M?????? | Director · Chief Operating Officer | filed 2014–2015 |
| NPS Pharmaceuticals INC NSPS | SVP, Chief Commercial Officer | filed 2007–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.